-
Evaluation of the RXR Agonist Compound IRX4204
… following oral administration. Study Design: A contract research laboratory tested IRX4204 and its brain penetration in a pre-clinical model of PD. Impact on Diagnosis/Treatment of Parkinson’s Disease: A … Research Grant …
-
Self-reported Perceptions and Self-reported Outcomes on Motor and Non-motor Symptoms in the Parkinson's Disease Continuum: A Systematic Review of Mixed Methods
… with Parkinson's Disease and their care partners. Impact on Diagnosis/Treatment of Parkinson’s disease: This study has the potential to impact the delivery of clinical and research plans that meet end-user preferences and needs by … Research Grant …
-
(SUPPLEMENT) Cataloguing Proteomic Differences in LRRK2-Associated Parkinsonism With and Without Evidence of Pathologic Neuronal Alpha-synuclein
… This grant builds upon the research from a prior grant: Developing Biomarker Signatures … for abnormal alpha-synuclein to those who do not. Impact on Diagnosis/Treatment of Parkinson’s disease: Understanding … Research Grant …
-
Developing an ELISA Immunoassay for Monitoring Phosphorylation of Proteins Associated with Parkinson’s Disease
… we will validate and commercialize the assay. Impact on Diagnosis/Treatment of Parkinson’s disease: This new tool … further clinical use, as this assay is being developed for Research Use Only. … Research Grant …
-
Searching for the Cause of Parkinson’s Disease in People with GBA Mutations
… to enroll in the study, we will prepare a detailed research plan. Impact on Diagnosis/Treatment of Parkinson’s disease: Knowing the … Research Grant …
-
Rab Detection Initiative and LRRK2 Detection Initiative Supplemental Support RDI, and LCC exosome replication
… This grant builds upon the research from a prior grant: Rab Detection Initiative Study … models treated with LRRK2 kinase inhibitors. Impact on Diagnosis/Treatment of Parkinson's disease: LRRK2 and Rab … Research Grant …